Co-opting Moore's law: Therapeutics, vaccines and interfacially active particles manufactured via PRINT®

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Co-opting Moore's law: Therapeutics, vaccines and interfacially active particles manufactured via PRINT®
Authors
Keywords
Nanoparticle, PRINT, cGMP delivery vehicle, Liquidia technologies, Team-based science, Clinical trials, Particle engineering, Drug delivery vehicle, Particulate vaccine, Calibration quality particles
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 240, Issue -, Pages 541-543
Publisher
Elsevier BV
Online
2016-07-17
DOI
10.1016/j.jconrel.2016.07.019

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.